|
|
|
|
||
The closer we get, the lower the stock price.Kind of strange, but the closer we get to completing the filing with the FDA, the lower the stock price. Unless, this action is related to OMIDRIA potentially losing reimbursement in October. Anybody have an opinion on the trading action? |
return to message board, top of board |